Koo Ja Seung, Kim Min Jung, Kim Eun-Kyung, Park Byeong-Woo
Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):108-15. doi: 10.1097/pai.0b013e318235a917.
This study investigated the usefulness of immunohistochemical staining for cytokeratin (CK) 5/6 and p63 for the precise categorization of papillary lesions by core needle biopsy (CNB) through correlations of CNB and subsequent surgical excision results. We retrospectively reviewed 75 cases with both CNB and subsequent surgical excision showing papillary lesions on immunohistochemistry for CK5/6 and p63. Histologic and immunohistochemical criteria used to classify papillary lesions were applied equally to the CNB and surgical excision samples. Final diagnostic concordance with clinical significance was noted in 69 (92.0%) cases. Six cases had diagnostic discrepancies that changed from papilloma with atypical ductal hyperplasia (ADH) to papilloma in 1 case, from papilloma with ADH to papilloma with usual ductal hyperplasia in 3 cases, and from papilloma with ductal carcinoma in situ to papilloma with ADH in 2 cases. In conclusion, although the results of CK5/6 and p63 in CNBs of papillary neoplasms were mostly representative of the final results for CK5/6 and p63 in subsequent surgical excisions, excisional biopsy is required for definitive subtyping due to the heterogeneous nature of papillary lesions and the possibility of overdiagnosis of papilloma with ductal carcinoma in situ in CNB, resulting in unnecessary radiation and hormone therapy.
本研究通过芯针活检(CNB)与后续手术切除结果的相关性,探讨细胞角蛋白(CK)5/6和p63免疫组化染色对乳头状病变进行精确分类的实用性。我们回顾性分析了75例同时进行了CNB及后续手术切除的病例,这些病例的CK5/6和p63免疫组化结果显示为乳头状病变。用于分类乳头状病变的组织学和免疫组化标准同样适用于CNB和手术切除样本。69例(92.0%)病例最终诊断具有临床意义的一致性。6例存在诊断差异,其中1例从伴有非典型导管增生(ADH)的乳头状瘤变为乳头状瘤,3例从伴有ADH的乳头状瘤变为伴有普通导管增生的乳头状瘤,2例从伴有原位导管癌的乳头状瘤变为伴有ADH的乳头状瘤。总之,尽管乳头状肿瘤CNB中CK5/6和p63的结果大多代表了后续手术切除中CK5/6和p63的最终结果,但由于乳头状病变的异质性以及CNB中伴有原位导管癌的乳头状瘤可能过度诊断,导致不必要的放疗和激素治疗,因此明确亚型仍需要切除活检。